These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31493387)

  • 1. Association with lipids or detergents is essential for preservation of the active structure of lipoprotein-associated phospholipase A
    Zhuo S; Yuan C
    Chem Phys Lipids; 2019 Dec; 225():104814. PubMed ID: 31493387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active site competition is the mechanism for the inhibition of lipoprotein-associated phospholipase A
    Zhuo S; Yuan C
    Sci Rep; 2020 Oct; 10(1):17232. PubMed ID: 33057060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a non-synonymous Q281R polymorphism on structure of human Lipoprotein-Associated Phospholipase A
    Gurung AB; Bhattacharjee A
    J Cell Biochem; 2018 Aug; 119(8):7009-7021. PubMed ID: 29737567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
    Tellis CC; Tselepis AD
    Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical differences in the mass and activity tests of lipoprotein-associated phospholipase A
    Zhuo S; Wolfert RL; Yuan C
    Clin Biochem; 2017 Dec; 50(18):1209-1215. PubMed ID: 28899631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of Lipoprotein-Associated Phospholipase A2 by Use of 3 Different Methods: Exploration of Discordance between ELISA and Activity Assays.
    Topbas C; Swick A; Razavi M; Anderson NL; Pearson TW; Bystrom C
    Clin Chem; 2018 Apr; 64(4):697-704. PubMed ID: 29321128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
    Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids.
    Jackisch L; Kumsaiyai W; Moore JD; Al-Daghri N; Kyrou I; Barber TM; Randeva H; Kumar S; Tripathi G; McTernan PG
    Diabetologia; 2018 May; 61(5):1155-1166. PubMed ID: 29427237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and Thermodynamic Characterization of Protein-Ligand Interactions Formed between Lipoprotein-Associated Phospholipase A2 and Inhibitors.
    Liu Q; Chen X; Chen W; Yuan X; Su H; Shen J; Xu Y
    J Med Chem; 2016 May; 59(10):5115-20. PubMed ID: 27078579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tyrosine nitration at positions Tyr307 and Tyr335 on structural dynamics of Lipoprotein-associated phospholipase A
    Gurung AB; Bhattacharjee A
    Int J Biol Macromol; 2018 Feb; 107(Pt B):1956-1964. PubMed ID: 29051098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2: how effective as a risk marker of cardiovascular disease and as a therapeutic target?
    Ahmed MS; Ji JZ; Meng QH
    Inflamm Allergy Drug Targets; 2011 Aug; 10(4):236-46. PubMed ID: 21539512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A
    Mouchlis VD; Hayashi D; Vasquez AM; Cao J; McCammon JA; Dennis EA
    Proc Natl Acad Sci U S A; 2022 Jan; 119(2):. PubMed ID: 34996868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance Characteristics and Clinical Value of the Lipoprotein-Associated Phospholipase A2 by an Enzymatic Kinetic Method.
    Lu M; Lv L
    Lab Med; 2019 Jul; 50(3):273-278. PubMed ID: 30770710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes.
    Passaro A; Vigna GB; Romani A; Sanz JM; Cavicchio C; Bonaccorsi G; Valacchi G; Cervellati C
    Oxid Med Cell Longev; 2018; 2018():1752940. PubMed ID: 30524650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Met117 oxidation leads to enhanced flexibility of cardiovascular biomarker- lipoprotein- associated phospholipase A
    Gurung AB; Bhattacharjee A
    Int J Biol Macromol; 2018 Jun; 112():831-840. PubMed ID: 29427679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy Intake and Plasma Adiponectin as Potential Determinants of Lipoprotein-Associated Phospholipase A
    Ntzouvani A; Giannopoulou E; Fragopoulou E; Nomikos T; Antonopoulou S
    Lipids; 2019 Oct; 54(10):629-640. PubMed ID: 31489677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-associated phospholipase A
    Öngen B; Kalkan Uçar S; Levent E; Azarsız E; Koloğlu T; Çoker M; Sözmen E; Sağın FG
    Ann Clin Biochem; 2017 Sep; 54(5):539-547. PubMed ID: 27614353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study].
    Chen J; Cai HW; Miao J; Xu XM; Mao W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):703-8. PubMed ID: 27491230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.